サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1409718

出生前DNAシーケンシングの世界市場レポート 2024年

Prenatal DNA Sequencing Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
出生前DNAシーケンシングの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

出生前DNAシーケンシングの市場規模は近年急速に拡大しています。2023年の22億3,000万米ドルから2024年には25億6,000万米ドルに、CAGR14.7％で拡大します。過去の期間に見られた成長は、患者の嗜好の変化、医療分野における進歩や研究、非侵襲的検査の採用増加、妊婦年齢の上昇、出生前DNAシーケンシングの精度と信頼性の向上に起因しています。

出生前DNAシーケンシング市場規模は、今後数年で急成長が見込まれます。2028年にはCAGR15.5％で45億6,000万米ドルに成長します。予測期間中に予想される成長は、早期発見に対する消費者の需要、妊産婦年齢の上昇と関連する妊娠リスク、公衆衛生への取り組み、規制機関からの支援とガイドラインの遵守、データ分析の進歩に起因すると考えられます。予測期間中に予想される注目すべき動向には、研究開発の強化、倫理と規制の枠組みに関する考慮、データ解釈ツールの強化、精密医療の統合、出生前遺伝カウンセリングの促進などが含まれます。

予想されるがん罹患率の上昇が出生前DNAシーケンシング市場の成長を牽引します。制御不能な細胞増殖と拡散を特徴とするがんは、胎児の異数性を検出し、胎児のがんを特定するために出生前DNAシーケンシングの使用を促します。このシークエンシング法は、人のがん感受性に影響する遺伝性あるいは生殖細胞系列のDNA変化を明らかにします。例えば、2023年1月のアメリカがん協会のデータによると、がん罹患者数は2021年の1,898,160人から2023年には1,958,310人と3.16％増加しています。その結果、がんの有病率は出生前DNAシーケンシング市場を牽引する原動力となっています。

出生率の増加は、出生前DNAシーケンシング市場の成長に貢献すると予測されます。出生率とは、特定の人口および期間における人口1,000人当たりの出生数を示すもので、胎児の遺伝子異常を特定するための出生前DNAシーケンシングの使用と一致しています。これは、十分な情報に基づいた生殖に関する意思決定や、出産時の選択的介入を実施するのに役立ちます。2022年5月、米国疾病予防管理センター（CDC）は、米国の出生数が2020年と比較して1％増加し、2021年の合計出生数が365万9,289人に達したと報告しました。2021年の出生率も全体で1％上昇し、15～44歳の女性1,000人当たりの出生数は56.6人となった。このように、出生率の上昇は出生前DNAシーケンシング市場の牽引要因となっています。

2023年の出生前DNAシーケンシング市場で最大の地域は北米でした。出生前DNAシーケンシング市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 出生前DNAシーケンシング市場の特徴

第3章 出生前DNAシーケンシング市場の動向と戦略

第4章 出生前DNAシーケンシング市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の出生前DNAシーケンシング市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 出生前DNAシーケンシング市場セグメンテーション

  • 世界の出生前DNAシーケンシング市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 遺伝病
  • 非遺伝性疾患
  • 世界の出生前DNAシーケンシング市場、用途別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 血友病
  • ダウン症
  • 嚢胞性線維症
  • 自閉症
  • ディジョージ症候群
  • エイズ（後天性免疫不全症候群）
  • がん
  • その他の用途
  • 世界の出生前DNAシーケンシング市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 学術研究
  • 臨床研究
  • 病院と診療所
  • 製薬会社およびバイオテクノロジー会社
  • その他のエンドユーザー

第7章 出生前DNAシーケンシング市場の地域および国分析

  • 世界の出生前DNAシーケンシング市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の出生前DNAシーケンシング市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋の出生前DNAシーケンシング市場

第9章 中国の出生前DNAシーケンシング市場

第10章 インドの出生前DNAシーケンシング市場

第11章 日本の出生前DNAシーケンシング市場

第12章 オーストラリアの出生前DNAシーケンシング市場

第13章 インドネシアの出生前DNAシーケンシング市場

第14章 韓国の出生前DNAシーケンシング市場

第15章 西欧の出生前DNAシーケンシング市場

第16章 英国の出生前DNAシーケンシング市場

第17章 ドイツの出生前DNAシーケンシング市場

第18章 フランスの出生前DNAシーケンシング市場

第19章 イタリアの出生前DNAシーケンシング市場

第20章 スペインの出生前DNAシーケンシング市場

第21章 東欧の出生前DNAシーケンシング市場

第22章 ロシアの出生前DNAシーケンシング市場

第23章 北米の出生前DNAシーケンシング市場

第24章 米国の出生前DNAシーケンシング市場

第25章 カナダの出生前DNAシーケンシング市場

第26章 南米の出生前DNAシーケンシング市場

第27章 ブラジルの出生前DNAシーケンシング市場

第28章 中東の出生前DNAシーケンシング市場

第29章 アフリカの出生前DNAシーケンシング市場

第30章 出生前DNAシーケンシング市場の競合情勢と企業プロファイル

  • 出生前DNAシーケンシング市場の競合情勢
  • 出生前DNAシーケンシング市場の企業プロファイル
    • Agilent Technologies Inc.
    • BGI Group
    • F. Hoffmann-La Roche Ltd
    • Illumina Inc.
    • Laboratory Corporation of America Holdings

第31章 世界の出生前DNAシーケンシング市場の競合ベンチマーキング

第32章 世界の出生前DNAシーケンシング市場競争ダッシュボード

第33章 出生前DNAシーケンシング市場における主要な合併と買収

第34章 出生前DNAシーケンシング市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r11256

“Prenatal DNA Sequencing Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prenatal dank sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prenatal dank sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The prenatal dank sequencing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Genetic Diseases; Nonhereditary Diseases
  • 2) By Application: Hemophilia; Down Syndrome; Cystic Fibrosis; Autism; DiGeorge Syndrome; AIDS (Acquired Immunodeficiency Syndrome); Cancer; Other Applications
  • 3) By End User: Academic Research; Clinical Research; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users
  • Companies Mentioned: Agilent Technologies Inc.; BGI Group; F. Hoffmann-La Roche Ltd; Illumina Inc.; Laboratory Corporation of America Holdings
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Prenatal DNA sequencing is a method employed to sequence the DNA of an unborn baby, utilizing a blood sample from the mother to unveil the complete genetic code of the fetus. This technique is instrumental in detecting fetal disorders or diseases.

The primary types of prenatal DNA sequencing encompass genetic diseases and nonhereditary diseases. Genetic diseases refer to disorders or diseases caused by mutations in one or more genes. DNA sequencing plays a crucial role in determining whether a gene carries a mutation leading to a specific disorder. Applications of prenatal DNA sequencing include conditions such as hemophilia, Down syndrome, cystic fibrosis, autism, DiGeorge syndrome, AIDS, cancer, and others. Various users, including academic research, clinical research, hospitals and clinics, as well as pharmaceutical and biotechnology companies, employ this technology.

The prenatal DNA sequencing market research report is one of a series of new reports from The Business Research Company that provides prenatal DNA sequencing market statistics, including the prenatal DNA sequencing industry global market size, regional shares, competitors with a prenatal DNA sequencing market share, detailed prenatal DNA sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal DNA sequencing industry. This prenatal DNA sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prenatal dna sequencing market size has grown rapidly in recent years. It will grow from $2.23 billion in 2023 to $2.56 billion in 2024 at a compound annual growth rate (CAGR) of 14.7%. The growth observed in the historical period can be attributed to changes in patient preferences, advancements and research in the medical field, increased adoption of non-invasive testing, a rise in maternal age, and enhancements in the accuracy and reliability of prenatal DNA sequencing.

The prenatal dna sequencing market size is expected to see rapid growth in the next few years. It will grow to $4.56 billion in 2028 at a compound annual growth rate (CAGR) of 15.5%. The anticipated growth in the forecast period can be attributed to consumer demand for early detection, an increase in maternal age and associated pregnancy risks, public health initiatives, support from regulatory bodies and adherence to guidelines, and advancements in data analysis. Noteworthy trends expected in the forecast period include intensified research and development efforts, considerations related to ethics and regulatory frameworks, enhancements in data interpretation tools, integration of precision medicine, and the promotion of prenatal genetic counseling.

The anticipated rise in cancer prevalence is set to drive the growth of the prenatal DNA sequencing market. Cancer, characterized by uncontrolled cell growth and spread, prompts the use of prenatal DNA sequencing to detect fetal aneuploidy and identify cancer in the fetus. This sequencing method unveils inherited or germline DNA changes influencing a person's cancer susceptibility. For example, data from the American Cancer Society in January 2023 showed an increase in cancer cases from 1,898,160 in 2021 to 1,958,310 in 2023, reflecting a growth rate of 3.16%. Consequently, the prevalence of cancer acts as a driving force for the prenatal DNA sequencing market.

The expected increase in the birth rate is poised to contribute to the growth of the prenatal DNA sequencing market. Birth rate, indicating the number of live births per 1,000 people in a specified population and time period, aligns with the use of prenatal DNA sequencing to identify genetic abnormalities in unborn fetuses. This aids in making informed reproductive decisions and implementing selective interventions during birth. In May 2022, the Centers for Disease Control and Prevention (CDC) reported a 1% rise in U.S. births compared to 2020, reaching a total of 3,659,289 births in 2021. The overall fertility rate for 2021 also increased by 1%, standing at 56.6 births per 1,000 women aged 15-44. Thus, the higher birth rate acts as a driving factor for the prenatal DNA sequencing market.

Product innovation is a prominent trend in the prenatal DNA sequencing market, with major companies concentrating on developing innovative solutions to enhance their market standing. Juno Diagnostics, Inc., a U.S.-based health technology company, introduced the noninvasive prenatal screening test 'Hazel' in November 2022. Designed with no risk of miscarriage, the test can be performed as early as 9 weeks into pregnancy using a small blood sample. It screens for common genetic conditions such as Down syndrome, Edwards syndrome, and Patau syndrome.

Major companies in the prenatal DNA sequencing market are actively developing compliance solutions, such as CE-IVD compliance solutions, to offer a next-generation sequencing approach to noninvasive prenatal testing (NIPT). Illumina, a U.S.-based life science tools developer, partnered with Next Generation Genomic in June 2021 to launch VeriSeq NIPT Solution v2 in Thailand. This CE-IVD next-generation sequencing-based approach expands prenatal screening beyond common aneuploidies to rare autosomal aneuploidies, sex chromosome aneuploidies, and large partial duplications and deletions.

In November 2022, Myriad Genetics, Inc., a U.S.-based provider of genetic testing and precision medicine, acquired Gateway Genomics, LLC, a personal genomics and prenatal DNA company. The undisclosed acquisition is expected to enhance Myriad's women's health product portfolio and provide access to personalized genetic tests, strengthening its position in the market.

Major companies operating in the prenatal dna sequencing market report are Agilent Technologies Inc., BGI Group, F. Hoffmann-La Roche Ltd, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., Genomic Health Inc., Myriad Genetics Inc., Invitae Corporation, PerkinElmer Inc., Macrogen Inc., Pacific Biosciences of California Inc., Genewiz LLC, 10x Genomics Inc., Oxford Nanopore Technologies Limited, Thermo Fisher Scientific Inc., Berry Genomics Co. Ltd., Centrillion Technology Holdings Corp., Cynvenio Biosystems Inc., Eurofins LifeCodexx AG, Fluidigm Corp., GATC Biotech AG, GeneDx Inc., Genoma SA, Good Start Genetics Inc., Helix OpCo LLC, Igenomix S.L., Integrated DNA Technologies Inc., KellBenx Inc., LifeCodexx AG .

North America was the largest region in the prenatal DNA sequencing market in 2023. The regions covered in the prenatal dna sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the prenatal dna sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The prenatal DNA sequencing market includes revenues earned by entities by provide services such as prenatal next-generation sequencing, whole genome sequencing, DNA extraction, DNA fragmentation, and data collection and sequence analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Prenatal DNA Sequencing Market Characteristics

3. Prenatal DNA Sequencing Market Trends And Strategies

4. Prenatal DNA Sequencing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Prenatal DNA Sequencing Market Size and Growth

  • 5.1. Global Prenatal DNA Sequencing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Prenatal DNA Sequencing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Prenatal DNA Sequencing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Prenatal DNA Sequencing Market Segmentation

  • 6.1. Global Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Genetic Diseases
  • Nonhereditary Diseases
  • 6.2. Global Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hemophilia
  • Down Syndrome
  • Cystic Fibrosis
  • Autism
  • DiGeorgre Syndrome
  • AIDS (Acquired Immunodeficiency Syndrome)
  • Cancer
  • Other Applications
  • 6.3. Global Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic Research
  • Clinical Research
  • Hospitals And Clinics
  • Pharmaceutical And Biotechnology Companies
  • Other End Users

7. Prenatal DNA Sequencing Market Regional And Country Analysis

  • 7.1. Global Prenatal DNA Sequencing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Prenatal DNA Sequencing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Prenatal DNA Sequencing Market

  • 8.1. Asia-Pacific Prenatal DNA Sequencing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Prenatal DNA Sequencing Market

  • 9.1. China Prenatal DNA Sequencing Market Overview
  • 9.2. China Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Prenatal DNA Sequencing Market

  • 10.1. India Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Prenatal DNA Sequencing Market

  • 11.1. Japan Prenatal DNA Sequencing Market Overview
  • 11.2. Japan Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Prenatal DNA Sequencing Market

  • 12.1. Australia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Prenatal DNA Sequencing Market

  • 13.1. Indonesia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Prenatal DNA Sequencing Market

  • 14.1. South Korea Prenatal DNA Sequencing Market Overview
  • 14.2. South Korea Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Prenatal DNA Sequencing Market

  • 15.1. Western Europe Prenatal DNA Sequencing Market Overview
  • 15.2. Western Europe Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Prenatal DNA Sequencing Market

  • 16.1. UK Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Prenatal DNA Sequencing Market

  • 17.1. Germany Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Prenatal DNA Sequencing Market

  • 18.1. France Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Prenatal DNA Sequencing Market

  • 19.1. Italy Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Prenatal DNA Sequencing Market

  • 20.1. Spain Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Prenatal DNA Sequencing Market

  • 21.1. Eastern Europe Prenatal DNA Sequencing Market Overview
  • 21.2. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Prenatal DNA Sequencing Market

  • 22.1. Russia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Prenatal DNA Sequencing Market

  • 23.1. North America Prenatal DNA Sequencing Market Overview
  • 23.2. North America Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Prenatal DNA Sequencing Market

  • 24.1. USA Prenatal DNA Sequencing Market Overview
  • 24.2. USA Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Prenatal DNA Sequencing Market

  • 25.1. Canada Prenatal DNA Sequencing Market Overview
  • 25.2. Canada Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Prenatal DNA Sequencing Market

  • 26.1. South America Prenatal DNA Sequencing Market Overview
  • 26.2. South America Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Prenatal DNA Sequencing Market

  • 27.1. Brazil Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Prenatal DNA Sequencing Market

  • 28.1. Middle East Prenatal DNA Sequencing Market Overview
  • 28.2. Middle East Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Prenatal DNA Sequencing Market

  • 29.1. Africa Prenatal DNA Sequencing Market Overview
  • 29.2. Africa Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Prenatal DNA Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Prenatal DNA Sequencing Market Competitive Landscape
  • 30.2. Prenatal DNA Sequencing Market Company Profiles
    • 30.2.1. Agilent Technologies Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. BGI Group
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. F. Hoffmann-La Roche Ltd
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Illumina Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Laboratory Corporation of America Holdings
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Prenatal DNA Sequencing Market Competitive Benchmarking

32. Global Prenatal DNA Sequencing Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Prenatal DNA Sequencing Market

34. Prenatal DNA Sequencing Market Future Outlook and Potential Analysis

  • 34.1 Prenatal DNA Sequencing Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Prenatal DNA Sequencing Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Prenatal DNA Sequencing Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer